Intestinal metabolites and the risk of autistic spectrum disorder: A two-sample Mendelian randomization study.

Liu, Deyang; Bu, Dengyin; Li, Hong; Wang, Qingsong; Ding, Xudong; Fang, Xiaolu

Liu, Deyang; Bu, Dengyin; Li, Hong; Wang, Qingsong; Ding, Xudong; Fang, Xiaolu.

Afiliación

Liu D; Department of Rehabilitation Medicine, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, China.
Bu D; Department of Psychiatric Medicine, Xiangyang Central Hospital, Hubei University of Arts and Science, Xiangyang, China.
Li H; Department of Rehabilitation Medicine, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, China.
Wang Q; Department of Rehabilitation Medicine, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, China.
Ding X; Department of Rehabilitation Medicine, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, China.
Fang X; Department of Clinical Laboratory, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, China.

Front Psychiatry ; 13: 1034214, 2022.

Article en En | MEDLINE | ID: mdl-36713927

Palabras clave

Mendelian randomization; autistic spectrum disorder; gut-brain axis; intestinal metabolites; serotonin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google